BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Betaferon® Regulatory Post-Marketing Surveillance
Completed
- Conditions
- Clinically Isolated SystemMultiple Sclerosis
- Interventions
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 355
- Registration Number
- NCT01414816
Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)
Phase 3
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2011-08-10
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 575
- Registration Number
- NCT01413958
Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan
Completed
- Conditions
- Hyperphosphatemia
- Interventions
- Drug: Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2018-01-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 446
- Registration Number
- NCT01412398
Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Bayer
- Target Recruit Count
- 117
- Registration Number
- NCT01412671
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 55
- Registration Number
- NCT01411410
Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3305
- Registration Number
- NCT01411423
Primovist Post-marketing Surveillance in Japan
Completed
- Conditions
- Diagnostic Imaging
- Interventions
- Drug: Gadoxetic Acid Disodium (Primovist, BAY86-4873)
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2030
- Registration Number
- NCT01411449
Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2015-03-04
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1637
- Registration Number
- NCT01411436
HPA Axis Study in Adults
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Bayer
- Target Recruit Count
- 23
- Registration Number
- NCT01408511
- Locations
- 🇿🇦
PAREXEL Port Elizabeth, Port Elizabeth, South Africa
🇿🇦PAREXEL Bloemfontein, Bloemfontein, South Africa
🇿🇦PAREXEL George, George, South Africa
HPA Axis Study in Japanese Adults
- First Posted Date
- 2011-08-02
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 12
- Registration Number
- NCT01407510
- Locations
- 🇯🇵
Clinical Research Hospital Tokyo, Tokyo, Japan
🇯🇵Kawaguchi Kogyo General Hospital, Saitama, Japan
🇯🇵Tokyo Women's Medical University, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath